Cannabis is not an effective treatment for common mental health conditions, says review | Cannabis

by Chief Editor

Cannabis and Mental Health: A Growing Disconnect Between Perception and Evidence

Despite a surge in patients seeking cannabis for mental health conditions, a comprehensive review published in The Lancet Psychiatry has found “very little evidence for its efficacy” in treating common disorders. The research, conducted by experts from Australia and England, casts a shadow over the rapidly expanding legal cannabis market and challenges the perceptions of many patients and clinicians.

The Widening Gap: Usage vs. Proven Benefit

The review analyzed 54 randomized controlled trials involving over 2,400 participants, focusing on conditions like anxiety, anorexia nervosa, PTSD, and opioid use disorder. Researchers found no significant positive effects on outcomes for these conditions. Evidence suggested modest benefits for reducing dependence on cannabis itself, relieving Tourette’s syndrome symptoms, and aiding sleep, but these findings were often based on “low” quality evidence.

This disconnect is particularly striking given the increasing legalization of cannabis for both mental and physical health issues across countries like the US, UK, Australia, and Canada. Clinics dispensing medical cannabis report that mental illnesses, particularly anxiety and depression, are the most frequently cited reasons for patient use, often alongside chronic pain.

Australia’s Cannabis Boom and the Search for Evidence

Australia, in particular, has seen a dramatic increase in medical cannabis imports – a 959% rise in just three years. A recent market forecast anticipates continued growth in the Australian legal cannabis market, fueled by clinical research and shifting public perceptions. However, this growth is occurring alongside a lack of robust evidence supporting its widespread use for mental health.

Did you know? The Advisory Council on the Misuse of Drugs in the UK is currently reviewing the effectiveness of cannabis-based products for medicinal use, including an assessment of any unintended consequences since legalization in 2018.

Paranoia and Potential Risks

Beyond the lack of efficacy, research also highlights potential risks. Studies indicate that cannabis use can significantly increase paranoia, a concerning side effect for individuals already vulnerable to mental health challenges. This finding underscores the importance of cautious prescribing and thorough patient evaluation.

Industry Response and Differing Perspectives

The Cannabis Industry Council argues that real-world evidence, including findings from the T21 study, demonstrates symptom reduction for anxiety and PTSD. Mike Morgan-Giles, the Council’s CEO, emphasizes the need for patients with psychiatric conditions to have access to treatment options. However, some experts, like Professor Sir Robin Murray of King’s College London, are more critical, suggesting that UK cannabis clinics operate more like “drug dealers for the middle class” due to overstated therapeutic benefits.

What Does This Mean for the Future?

The research suggests a need for more rigorous clinical trials to determine the true potential of cannabinoids in treating mental health disorders. Currently, the evidence base does not justify the routine use of cannabis for these conditions.

Pro Tip: If you are considering cannabis for a mental health condition, discuss the potential risks and benefits with a qualified healthcare professional. Be sure to request about the quality of evidence supporting its use for your specific condition.

FAQ

Q: Does cannabis help with anxiety?
A: The recent review found no significant evidence that cannabis is effective in treating anxiety.

Q: Is medical cannabis legal in Australia?
A: Yes, but access is regulated, and the market is rapidly evolving. Imports have increased significantly in recent years.

Q: Can cannabis cause negative side effects?
A: Yes, cannabis can increase paranoia and may have other side effects. It’s important to discuss these with a doctor.

Q: What is the UK doing about medical cannabis?
A: The Advisory Council on the Misuse of Drugs is reviewing the current regulations and assessing unintended consequences.

Do you have questions about medical cannabis and mental health? Share your thoughts in the comments below!

You may also like

Leave a Comment